QuickView for GPS2;jsessionid=5DEFB28AA6506D852E208E7810A68700;jsessionid=CD54B24BC0A57EED6A1F17BE26560BAB;jsessionid=D901123A2F4DF7A8F6490DA889EF4FA6 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Testes
Testis seminiferous tubule
Skeletal muscle
Jejunum
Whole blood

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Irritable bowel syndrome
Intestinal infectious disease
Sepsis due to Streptococcus agalactiae
Infection by Schistosoma
Systemic infection

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

carbetapentane
Mesalamine
SU 5402
harpagoside
Indapamide

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

21099
21098
NANOGP8
P2RY14
EIF4A1

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

GPS2-mediated regulation of the adipocyte secretome modulates adipose tissue remodeling at the onset…
Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor sup…
Adipocyte Reprogramming by the Transcriptional Coregulator GPS2 Impacts Beta Cell Insulin Secretion.
GPS2 promotes erythroid differentiation by control of the stability of EKLF protein.
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPA…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for GPS2;jsessionid=5DEFB28AA6506D852E208E7810A68700;jsessionid=CD54B24BC0A57EED6A1F17BE26560BAB;jsessionid=D901123A2F4DF7A8F6490DA889EF4FA6

Explore Clinical Trials Results